Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 234

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis

Rohrer, Jonathan D, Isaacs, Adrian M, Mizielinska, Sarah, Mead, Simon, Lashley, Tammaryn, Wray, Selina, Sidle, Katie, Fratta, Pietro, Orrell, Richard W, Hardy, John, Holton, Janice, Revesz, Tamas, Rossor, Martin N, Warren, Jason D·2015·The Lancet Neurology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(14)70233-9

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 117

  1. Gijselinck, 2012, A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study, Lancet Neurol, 11, 54, 10.1016/S1474-4422(11)70261-7 · DOI · Paper page
  2. van der Zee, 2013, A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats, Hum Mutat, 34, 363, 10.1002/humu.22244 · DOI · Paper page
  3. Ash, 2013, Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS, Neuron, 77, 639, 10.1016/j.neuron.2013.02.004 · DOI · Paper page
  4. Mori, 2013, The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS, Science, 339, 1335, 10.1126/science.1232927 · DOI · Paper page
  5. Gendron, 2014, Mechanisms of toxicity in C9FTLD/ALS, Acta Neuropathol, 127, 359, 10.1007/s00401-013-1237-z · DOI
  6. Jones, 2013, Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeat, Neurobiol Aging, 34, 2234.e1, 10.1016/j.neurobiolaging.2013.03.003 · DOI
  7. van Blitterswijk, 2013, Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study, Lancet Neurol, 12, 978, 10.1016/S1474-4422(13)70210-2 · DOI · Paper page
  8. Fratta, 2015, Screening a UK amyoytrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion, Neurobiol Aging, 36, 546.e1, 10.1016/j.neurobiolaging.2014.07.037 · DOI
  9. Dobson-Stone, 2013, C9ORF72 repeat expansion in Australian and Spanish frontotemporal dementia patients, PLoS One, 8, e56899, 10.1371/journal.pone.0056899 · DOI
  10. Buchman, 2013, Simultaneous and independent detection of C9ORF72 alleles with low and high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation, Mol Neurodegener, 8, 12, 10.1186/1750-1326-8-12 · DOI
  11. Dols-Icardo, 2014, Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia, Hum Mol Genet, 23, 749, 10.1093/hmg/ddt460 · DOI
  12. Gómez-Tortosa, 2013, C9ORF72 hexanucleotide expansions of 20–22 repeats are associated with frontotemporal deterioration, Neurology, 80, 366, 10.1212/WNL.0b013e31827f08ea · DOI
  13. Byrne, 2014, Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis, Amyotroph Lateral Scler Frontotemporal Degener, 15, 148, 10.3109/21678421.2013.838586 · DOI
  14. Simón-Sánchez, 2012, The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions, Brain, 135, 723, 10.1093/brain/awr353 · DOI · Paper page
  15. Akimoto, 2014, A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories, J Med Genet, 51, 419, 10.1136/jmedgenet-2014-102360 · DOI
  16. Pliner, 2014, Searching for Grendel: origin and global spread of the C9ORF72 repeat expansion, Acta Neuropathol, 127, 391, 10.1007/s00401-014-1250-x · DOI
  17. Mok, 2012, High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients, Neurobiol Aging, 33, 1851.e1, 10.1016/j.neurobiolaging.2012.02.021 · DOI
  18. Jiao, 2014, Identification of C9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China, Neurobiol Aging, 35, 936.e19, 10.1016/j.neurobiolaging.2013.10.001 · DOI
  19. Heutink, 2014, C9orf72; abnormal RNA expression is the key, Exp Neurol, 262, 102, 10.1016/j.expneurol.2014.05.020 · DOI
  20. Woollacott, 2014, The C9ORF72 expansion mutation: gene structure, phenotypic and diagnostic issues, Acta Neuropathol, 127, 319, 10.1007/s00401-014-1253-7 · DOI
  21. Norio, 2003, Finnish Disease Heritage I: characteristics, causes, background, Hum Genet, 112, 441, 10.1007/s00439-002-0875-3 · DOI · Paper page
  22. Norio, 2003, Finnish Disease Heritage II: population prehistory and genetic roots of Finns, Hum Genet, 112, 457, 10.1007/s00439-002-0876-2 · DOI
  23. Norio, 2003, The Finnish Disease Heritage III: the individual diseases, Hum Genet, 112, 470, 10.1007/s00439-002-0877-1 · DOI
  24. Hsiung, 2012, Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p, Brain, 135, 709, 10.1093/brain/awr354 · DOI · Paper page
  25. Mahoney, 2012, Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features, Brain, 135, 736, 10.1093/brain/awr361 · DOI · Paper page
  26. Dobson-Stone, 2012, C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts, Neurology, 79, 995, 10.1212/WNL.0b013e3182684634 · DOI
  27. Sha, 2012, Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features, Neurology, 79, 1002, 10.1212/WNL.0b013e318268452e · DOI · Paper page
  28. Devenney, 2014, Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile, JAMA Neurol, 71, 331, 10.1001/jamaneurol.2013.6002 · DOI · Paper page
  29. Englund, 2012, Familial Lund frontotemporal dementia caused by C9ORF72 hexanucleotide expansion, Neurobiol Aging, 33, 1850.e13, 10.1016/j.neurobiolaging.2012.02.019 · DOI
  30. Boeve, 2012, Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72, Brain, 135, 765, 10.1093/brain/aws004 · DOI · Paper page
  31. Chiò, 2012, Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72, Brain, 135, 784, 10.1093/brain/awr366 · DOI · Paper page
  32. Cooper-Knock, 2012, Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72, Brain, 135, 751, 10.1093/brain/awr365 · DOI · Paper page
  33. Byrne, 2012, Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study, Lancet Neurol, 11, 232, 10.1016/S1474-4422(12)70014-5 · DOI · Paper page
  34. Stewart, 2012, Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p, Acta Neuropathol, 123, 409, 10.1007/s00401-011-0937-5 · DOI
  35. Coon, 2013, Clinical and electrophysiologic variability in amyotrophic lateral sclerosis within a kindred harboring the C9ORF72 repeat expansion, Amyotroph Lateral Scler Frontotemporal Degener, 14, 132, 10.3109/17482968.2012.724075 · DOI
  36. Montuschi, 2015, Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy, J Neurol Neurosurg Psychiatry, 86, 168, 10.1136/jnnp-2013-307223 · DOI · Paper page
  37. Kertesz, 2013, Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort, Cogn Behav Neurol, 26, 146, 10.1097/WNN.0000000000000008 · DOI
  38. Galimberti, 2013, Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation, Biol Psychiatry, 74, 384, 10.1016/j.biopsych.2013.01.031 · DOI
  39. Arighi, 2012, Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations, J Alzheimers Dis, 31, 447, 10.3233/JAD-2012-120523 · DOI
  40. Calvo, 2012, Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene, J Neurol, 259, 2723, 10.1007/s00415-012-6640-1 · DOI
  41. Galimberti, 2014, The C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia, Neurobiol Aging, 35, 1214.e7, 10.1016/j.neurobiolaging.2013.12.004 · DOI · Paper page
  42. Galimberti, 2014, C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder, Bipolar Disord, 16, 448, 10.1111/bdi.12169 · DOI · Paper page
  43. Meisler, 2013, C9ORF72 expansion in a family with bipolar disorder, Bipolar Disord, 15, 326, 10.1111/bdi.12063 · DOI
  44. Bieniek, 2014, Expanded C9ORF72 hexanucleotide repeat in depressive pseudodementia, JAMA Neurol, 71, 775, 10.1001/jamaneurol.2013.6368 · DOI
  45. Wojtas, 2012, C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic, Am J Neurodegener Dis, 1, 107
  46. Murray, 2013, Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72, Acta Neuropathol, 126, 545, 10.1007/s00401-013-1161-2 · DOI
  47. Pletnikova, 2014, Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion, Neurobiol Aging, 35, 2419.e17, 10.1016/j.neurobiolaging.2014.04.009 · DOI
  48. Irish, 2013, Neural substrates of episodic memory dysfunction in behavioural variant frontotemporal dementia with and without C9ORF72 expansions, Neuroimage Clin, 2, 836, 10.1016/j.nicl.2013.06.005 · DOI
  49. Gorno-Tempini, 2011, Classification of primary progressive aphasia and its variants, Neurology, 76, 1006, 10.1212/WNL.0b013e31821103e6 · DOI · Paper page
  50. Van Langenhove, 2013, Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort, JAMA Neurol, 70, 365, 10.1001/2013.jamaneurol.181 · DOI
  51. Saint-Aubert, 2014, A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding, J Alzheimers Dis, 42, 413, 10.3233/JAD-140222 · doi:10.3233/jad-140222
  52. Millecamps, 2012, Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes, J Med Genet, 49, 258, 10.1136/jmedgenet-2011-100699 · DOI · Paper page
  53. van Rheenen, 2012, Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases, Neurology, 79, 878, 10.1212/WNL.0b013e3182661d14 · DOI
  54. Snowden, 2013, Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72, Amyotroph Lateral Scler Frontotemporal Degener, 14, 172, 10.3109/21678421.2013.765485 · DOI
  55. Siuda, 2014, Parkinsonian syndrome in familial frontotemporal dementia, Parkinsonism Relat Disord, 20, 957, 10.1016/j.parkreldis.2014.06.004 · DOI · Paper page
  56. Lesage, 2013, C9orf72 repeat expansions are a rare genetic cause of parkinsonism, Brain, 136, 385, 10.1093/brain/aws357 · DOI · Paper page
  57. Origone, 2013, Enlarging the clinical spectrum associated with C9orf 72 repeat expansions: findings in an Italian cohort of patients with parkinsonian syndromes and relevance for genetic counselling, Amyotroph Lateral Scler Frontotemporal Degener, 14, 479, 10.3109/21678421.2013.774020 · DOI
  58. Cooper-Knock, 2013, C9ORF72 expansions, parkinsonism, and Parkinson disease: a clinicopathologic study, Neurology, 81, 808, 10.1212/WNL.0b013e3182a2cc38 · DOI
  59. Nuytemans, 2013, C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease, Ann Hum Genet, 77, 351, 10.1111/ahg.12033 · DOI
  60. Robinson, 2014, C9ORF72 in Dementia with Lewy bodies, J Neurol Neurosurg Psychiatry, 85, 1435, 10.1136/jnnp-2014-307622 · DOI
  61. Goldman, 2014, Multiple system atrophy and amyotrophic lateral sclerosis in a family with hexanucleotide repeat expansions in C9orf72, JAMA Neurol, 71, 771, 10.1001/jamaneurol.2013.5762 · DOI
  62. Khan, 2012, Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion, J Neurol Neurosurg Psychiatry, 83, 358, 10.1136/jnnp-2011-301883 · DOI · Paper page
  63. Suhonen, 2014, Slowly progressive frontotemporal lobar degeneration caused by the C9ORF72 repeat expansion: a 20-year follow-up study, Neurocase, 21, 85, 10.1080/13554794.2013.873057 · DOI
  64. Gómez-Tortosa, 2014, Familial benign frontotemporal deterioration with C9ORF72 hexanucleotide expansion, Alzheimers Dement, 10, 284, 10.1016/j.jalz.2013.09.013 · DOI
  65. Gallagher, 2014, TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions, Acta Neuropathol, 127, 407, 10.1007/s00401-013-1239-x · DOI
  66. van Blitterswijk, 2014, TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia, Acta Neuropathol, 127, 397, 10.1007/s00401-013-1240-4 · DOI
  67. van Blitterswijk, 2014, Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers, Neurobiol Aging, 35, 2421.e13, 10.1016/j.neurobiolaging.2014.04.016 · DOI
  68. Fong, 2012, Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion, Alzheimers Res Ther, 4, 27, 10.1186/alzrt130 · DOI
  69. Chiò, 2014, Genetic counselling in ALS: facts, uncertainties and clinical suggestions, J Neurol Neurosurg Psychiatry, 85, 478, 10.1136/jnnp-2013-305546 · DOI
  70. van Blitterswijk, 2013, C9ORF72 repeat expansions in cases with previously identified pathogenic mutations, Neurology, 81, 1332, 10.1212/WNL.0b013e3182a8250c · DOI
  71. Chiò, 2012, ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations, J Neurol Neurosurg Psychiatry, 83, 730, 10.1136/jnnp-2012-302219 · DOI
  72. Kaivorinne, 2014, Novel TARDBP sequence variant and C9ORF72 repeat expansion in a family with frontotemporal dementia, Alzheimer Dis Assoc Disord, 28, 190, 10.1097/WAD.0b013e318266fae5 · DOI
  73. King, 2013, Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant, Acta Neuropathol, 125, 303, 10.1007/s00401-012-1050-0 · DOI
  74. Lashley, 2014, A pathogenic progranulin mutation and C9orf72 repeat expansion in a family with frontotemporal dementia, Neuropathol Appl Neurobiol, 40, 502, 10.1111/nan.12100 · DOI
  75. Mignarri, 2014, Double trouble? Progranulin mutation and C9ORF72 repeat expansion in a case of primary non-fluent aphasia, J Neurol Sci, 341, 176, 10.1016/j.jns.2014.03.030 · DOI
  76. Whitwell, 2012, Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics, Brain, 135, 794, 10.1093/brain/aws001 · DOI · Paper page
  77. Irwin, 2013, Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 84, 163, 10.1136/jnnp-2012-303507 · DOI
  78. Bede, 2013, Basal ganglia involvement in amyotrophic lateral sclerosis, Neurology, 81, 2107, 10.1212/01.wnl.0000437313.80913.2c · DOI · Paper page
  79. Rohrer, 2015, Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the GENFI study: cross-sectional analysis of baseline data, Lancet Neurol, 10.1016/S1474-4422(14)70324-2 · DOI · Paper page
  80. Bede, 2013, Multiparametric MRI study of ALS stratified for the C9orf72 genotype, Neurology, 81, 361, 10.1212/WNL.0b013e31829c5eee · DOI · Paper page
  81. Adeli, 2014, The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome, Neurocase, 20, 110, 10.1080/13554794.2012.732090 · DOI
  82. Cistaro, 2014, The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients, Eur J Nucl Med Mol Imaging, 41, 844, 10.1007/s00259-013-2667-5 · DOI · Paper page
  83. Chester, 2013, Rapidly progressive frontotemporal dementia and bulbar amyotrophic lateral sclerosis in Portuguese patients with C9orf72 mutation, Amyotroph Lateral Scler Frontotemporal Degener, 14, 70, 10.3109/17482968.2012.690418 · DOI
  84. Williams, 2013, Pathophysiological insights into ALS with C9ORF72 expansions, J Neurol Neurosurg Psychiatry, 84, 931, 10.1136/jnnp-2012-304529 · DOI
  85. Downey, 2012, Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion, Alzheimers Res Ther, 4, 42, 10.1186/alzrt145 · DOI
  86. Downey, 2014, Altered body schema processing in frontotemporal dementia with C9ORF72 mutations, J Neurol Neurosurg Psychiatry, 85, 1016, 10.1136/jnnp-2013-306995 · DOI · Paper page
  87. Mackenzie, 2011, A harmonized classification system for FTLD-TDP pathology, Acta Neuropathol, 122, 111, 10.1007/s00401-011-0845-8 · DOI · Paper page
  88. Murray, 2011, Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72, Acta Neuropathol, 122, 673, 10.1007/s00401-011-0907-y · DOI · Paper page
  89. Fratta, 2013, Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia, Acta Neuropathol, 126, 401, 10.1007/s00401-013-1147-0 · DOI
  90. Josephs, 2013, Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia, Brain, 136, 455, 10.1093/brain/aws324 · DOI
  91. Mori, 2013, hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations, Acta Neuropathol, 125, 413, 10.1007/s00401-013-1088-7 · DOI · Paper page
  92. Gendron, 2013, Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS, Acta Neuropathol, 126, 829, 10.1007/s00401-013-1192-8 · DOI · Paper page
  93. Mori, 2013, Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins, Acta Neuropathol, 126, 881, 10.1007/s00401-013-1189-3 · DOI · Paper page
  94. Davidson, 2014, Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72, Acta Neuropathol Commun, 2, 70, 10.1186/2051-5960-2-70 · DOI
  95. Belzil, 2013, Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood, Acta Neuropathol, 126, 895, 10.1007/s00401-013-1199-1 · DOI · Paper page
  96. Donnelly, 2013, RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention, Neuron, 80, 415, 10.1016/j.neuron.2013.10.015 · DOI · Paper page
  97. Xi, 2013, Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion, Am J Hum Genet, 92, 981, 10.1016/j.ajhg.2013.04.017 · DOI · Paper page
  98. Belzil, 2014, Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients, Brain Res, 1584, 15, 10.1016/j.brainres.2014.02.015 · DOI
  99. Levine, 2013, The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs, Bioinformatics, 29, 499, 10.1093/bioinformatics/bts725 · DOI · Paper page
  100. Zhang, 2012, Discovery of novel DENN proteins: implications for the evolution of eukaryotic intracellular membrane structures and human disease, Front Genet, 3, 283, 10.3389/fgene.2012.00283 · DOI · Paper page
  101. Therrien, 2013, Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans, PLoS One, 8, e83450, 10.1371/journal.pone.0083450 · DOI · Paper page
  102. Lagier-Tourenne, 2013, Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration, Proc Natl Acad Sci USA, 110, E4530, 10.1073/pnas.1318835110 · DOI · Paper page
  103. Fratta, 2012, C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes, Sci Rep, 2, 1016, 10.1038/srep01016 · DOI · Paper page
  104. Reddy, 2013, The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures, J Biol Chem, 288, 9860, 10.1074/jbc.C113.452532 · DOI · Paper page
  105. Zamiri, 2014, TMPyP4 porphyrin distorts RNA G-quadruplex structures of the disease-associated r(GGGGCC)n repeat of the C9orf72 gene and blocks interaction of RNA-binding proteins, J Biol Chem, 289, 4653, 10.1074/jbc.C113.502336 · DOI · Paper page
  106. Mizielinska, 2013, C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci, Acta Neuropathol, 126, 845, 10.1007/s00401-013-1200-z · DOI · Paper page
  107. Zu, 2013, RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia, Proc Natl Acad Sci USA, 110, E4968, 10.1073/pnas.1315438110 · DOI · Paper page
  108. Cooper-Knock, 2014, Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions, Brain, 137, 2040, 10.1093/brain/awu120 · DOI · Paper page
  109. Lee, 2013, Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic, Cell Reports, 5, 1178, 10.1016/j.celrep.2013.10.049 · DOI · Paper page
  110. Stepto, 2014, Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia, Acta Neuropathol, 127, 377, 10.1007/s00401-013-1235-1 · DOI
  111. Xu, 2013, Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration, Proc Natl Acad Sci USA, 110, 7778, 10.1073/pnas.1219643110 · DOI · Paper page
  112. May, 2014, C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration, Acta Neuropathol, 128, 485, 10.1007/s00401-014-1329-4 · DOI · Paper page
  113. Zhang, 2014, Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress, Acta Neuropathol, 128, 505, 10.1007/s00401-014-1336-5 · DOI · Paper page
  114. Kwon, 2014, Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells, Science, 345, 1139, 10.1126/science.1254917 · DOI · Paper page
  115. Su, 2014, Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS, Neuron, 83, 1043, 10.1016/j.neuron.2014.07.041 · DOI · Paper page
  116. Rohrer, 2013, Presymptomatic studies in genetic frontotemporal dementia, Rev Neurol (Paris), 169, 820, 10.1016/j.neurol.2013.07.010 · DOI
  117. Sha, 2012, Treatment implications of C9ORF72, Alzheimers Res Ther, 4, 46, 10.1186/alzrt149 · DOI

Cited by

See all 234

Metadata

Authors
Rohrer, J. D., Isaacs, A. M., Mizielinska, S., Mead, S., Lashley, T., Wray, S., Sidle, K., Fratta, P., Orrell, R. W., Hardy, J., Holton, J., Revesz, T., Rossor, M. N., & Warren, J. D.
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2015-03
Volume
14
Issue
3
Pages
291-301
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2149444716
Cited by
234
References
24
FWCI
26.32
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
Wellcome Trust Senior Clinical Fellowship (091673/Z/10/Z)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. https://app.cochat.ai/papers/10.1016/s1474-4422(14)70233-9
The paper
Rohrer, J. D., Isaacs, A. M., Mizielinska, S., Mead, S., Lashley, T., Wray, S., Sidle, K., Fratta, P., Orrell, R. W., Hardy, J., Holton, J., Revesz, T., Rossor, M. N., & Warren, J. D. (2015). C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(14)70233-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.